Providence Holy Cross Medical Center is the first Providence hospital in the San Fernando Valley to offer a minimally ...

Dedicated COPD respiratory therapists can improve inhaler use, ensure adherence, and bridge care transitions, explained Megan ...

Health Canada has approved Dupixent® (dupilumab injection) as an add-on maintenance treatment in adult patients with chronic ...

Respiratory diseases such as Asthma and Chronic Obstructive Pulmonary Disease (COPD) are on the rise partly because of ...

Merck & Co. Inc. (NYSE:MRK) is one of the best growth stocks to buy now. On October 7, Merck & Co. announced the completion ...

Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...

New findings from the ERS Global Congress on Lung Diseases present a paradigm shift in COPD treatment: Early identification of type 2 inflammation and personalized biologic therapy.

Ensifentrine significantly improved lung function after 12 weeks in patients with moderate to severe COPD with and without ...

Telemedicine significantly improved quality of life and inhaler technique in advanced COPD patients compared to traditional ...

AstraZeneca will cut drug costs for 9 million Americans under a White House agreement, aiming to make medications more ...

Learn how accelerating drug discovery is reshaping the pathway from lab findings to effective therapies with real-world data.

After 1 year of biologic therapy, admissions requiring noninvasive ventilation among patients with COPD and type 2 ...